Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study (Q90100203)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 September 2019

Language	Label	Description	Also known as
English	Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study	scientific article published on 13 September 2019

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

cholecystokinin

1 reference

based on heuristic

inferred from title

thyroid carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Roger Schibli

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

12

object named as

Martin Behe

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Christof Rottenburger

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Guillaume P Nicolas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Lisa McDougall

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Felix Kaul

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Michal Cachovan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

A Hans Vija

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Susanne Geistlich

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Anne Schumann

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Tilman Rau

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Katharina Glatz

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Emanuel R Christ

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Damian Wild

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

language of work or name

0 references

publication date

13 September 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

The Journal of Nuclear Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

61

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

520-526

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31519804 AND SRC:MED&resulttype=core&format=json

11 April 2020

Somatostatin receptors and somatostatin content in medullary thyroid carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indication for different mechanisms of kidney uptake of radiolabeled peptides.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly Improved Metabolic Stability and Pharmacokinetics of Indium-111-DOTA-Gastrin Conjugates for Targeting of the Gastrin Receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiopharmaceutical development of radiolabelled peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabozantinib in progressive medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of advanced medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elucidating the Structure-Activity Relationship of the Pentaglutamic Acid Sequence of Minigastrin with Cholecystokinin Receptor Subtype 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/31519804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q90100203&oldid=2249126382"